REVIAN, Inc.

REVIAN is an FDA-cleared medical device manufacturer specializing in at-home phototherapy systems for hair loss treatment and scalp rejuvenation. The company produces wireless, LED-based low-level light therapy (LLLT) caps utilizing patented dual-wavelength red light technology (620nm orange and 660nm red wavelengths). REVIAN's flagship products—REVIAN Red and REVIAN Lyte—are clinically proven to stimulate hair regrowth by enhancing scalp microcirculation, reducing inflammation, and modulating nitric oxide production. The devices feature integrated mobile app control for treatment tracking, compliance monitoring, and progress documentation. A double-blind, placebo-controlled clinical trial demonstrated that REVIAN Red achieved 26.3 new hairs/cm² at 16 weeks, outperforming minoxidil and finasteride. The company maintains relationships with 2,000+ U.S. dermatology providers and offers HSA/FSA financing. Products are covered by a 6-month money-back guarantee (with 80% compliance) and are designed for daily 10-minute home use.